Business Wire (Fri, 19-Apr 9:30 AM ET)
TipRanks (Mon, 15-Apr 4:20 AM ET)
HCA Healthcare, Inc. to Present at May Healthcare Conferences
Business Wire (Wed, 3-Apr 8:30 AM ET)
HCA Healthcare Releases 2024 Annual Impact Report
Business Wire (Thu, 28-Mar 8:30 AM ET)
HCA Healthcare, Inc. 1st Quarter 2024 Earnings Conference Call
Business Wire (Mon, 25-Mar 8:30 AM ET)
HCA Healthcare Names Dr. Monique Butler as President of Graduate Medical Education
Business Wire (Tue, 12-Mar 8:30 AM ET)
HCA Healthcare Named as One of the 2024 World's Most Ethical Companies by Ethisphere
Business Wire (Mon, 4-Mar 8:30 AM ET)
HCA Healthcare, Inc. to Present at March Healthcare Conference
Business Wire (Thu, 29-Feb 4:30 PM ET)
Business Wire (Thu, 22-Feb 4:30 PM ET)
HCA Announces Proposed Public Offering of Senior Notes
Business Wire (Tue, 20-Feb 8:37 AM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2022, the firm owned and operated 182 hospitals, 126 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of April 19, 2024, HCA stock price climbed to $305.11 with 1,464,752 million shares trading.
HCA has a beta of 0.98, meaning it tends to be less sensitive to market movements. HCA has a correlation of 0.24 to the broad based SPY ETF.
HCA has a market cap of $80.70 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $17 billion in Revenue and $5.90 earnings per share. This beat revenue expectation by $793 million and exceeded earnings estimates by $.86.
In the last 3 years, HCA stock traded as high as $335.83 and as low as $164.47.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
HCA has underperformed the market in the last year with a price return of +13.3% while the SPY ETF gained +21.2%. However, in the short term, HCA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +7.4% vs +4.3% return in SPY. But in the last 2 weeks, HCA shares have been beat by the market, returning -6.2% compared to an SPY return of -3.5%.
HCA support price is $292.64 and resistance is $301.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA stock will trade within this expected range on the day.